Dr. John Corboy, Co-Director of the Rocky Mountain MS Center at University of Colorado, has been named the inaugural Charles Elliot Morris Chair in Neurology. Dr. Corboy serves as Co-Director…
Read More
A recently adopted state law allows for the expanded use of home-based telehealth services in Colorado. Our partners at the Rocky Mountain MS Center at University of Colorado are in…
Pick Your Summit and Hit the Trails in Support of the RMMSC The 2019 MS4MS campaign is in full swing, and we hope you’ll join us on the trails this…
MS doesn’t mean losing your mind. Whether you are newly diagnosed or an experienced person with MS, understanding your changing cognitive challenges leads to identifying coping skills. Join the RMMSC and author…
The Rocky Mountain MS Center’s 2019 Spring Education Summit was held Saturday, April 13 at the Anschutz Medical Campus in Aurora. Below is a recap of the entire Summit, including…
The US Food and Drug Administration (FDA) has approved oral cladribine (brand named Mavenclad®, EMD Serono) for the treatment of adults with relapsing forms of MS, including relapsing-remitting MS and…
The US Food and Drug Administration (FDA) has approved oral Siponimod (brand named Mayzent®, Novartis International AG) to treat clinically isolated syndrome (an initial neurological episode), relapsing forms of MS,…
April 7-13, 2019 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals and…
April 7-13, 2019 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals and…
April 7-13, 2019 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…